Research

  • High-salt diet inflames the brain and could increase stroke risk, study suggests        

    A new study finds that a high-salt diet triggers brain inflammation that drives up blood pressure. The research, led by McGill University scientist Masha Prager-Khoutorsky in collaboration with an interdisciplinary team at McGill and the Research Institute of the McGill University Health Centre, suggests the brain may be a missing link in certain forms of [...]

  • Parkinson’s disease risk increases with metabolic syndrome, study finds        

    Having a larger waistline, high blood pressure and other risk factors that make up metabolic syndrome is associated with an increased risk of Parkinson’s disease, according to a new study. The study does not prove that metabolic syndrome causes Parkinson’s disease; it only shows an association. Metabolic syndrome is defined as having three or more [...]

  • Keto diet shows promise for MS, study finds

    A ketogenic diet may reduce fatigue, improve neurological function and enhance daily life for people with multiple sclerosis, new analysis suggests. The diet, which involves eating very little carbohydrate and replacing it with fat, was linked to benefits in six studies involving people with MS. Researchers stressed the evidence is limited but said the findings [...]

  • World’s first spinal cord transplant could allow patients to walk again

    Israel is preparing for what is described as the first human spinal cord implant using a patient’s own cells, in the hope of restoring walking ability. The surgery, expected in the coming months, aims to help paralysed patients stand and walk again by replacing damaged tissue with laboratory-grown cells. The procedure was developed [...]

  • New research reveals how nerve cells can be protected against ALS

    Researchers have discovered why some nerve cells resist ALS and identified protective factors that could open new paths for treatment. By examining millions of messenger RNA molecules during disease progression, scientists found that motor neurons controlling eye muscles resist ALS because they sustain high levels of protective proteins. The study focused on a hereditary form [...]

  • FDA gives go ahead for ONWARD Medical spinal study

    The FDA has approved a clinical study of an implantable device designed to stabilise blood pressure in people with spinal cord injury. The ARC-IM System, a neurostimulation device, will be tested in the Empower BP pivotal study across about 20 research centres, with patient enrolment expected before the end of 2025. Blood pressure instability affects [...]

  • Business Roundup: Advancing new therapies for Parkinson’s disease and more

    Neuro Rehab Times explores the latest business and pharmaceutical developments in the world of neuro-rehabilitation. US$32m to advance left atrial appendage occlusion technology Medical device company Conformal Medical, has raised US$32m to advance its left atrial appendage occlusion technology. The funds will support the enrolment of the company's ongoing CONFORM Pivotal Trial and [...]

  • ‘Mount Everest air’ offers clues to potential Parkinson’s breakthrough

    A low-oxygen environment, similar to air at Mount Everest base camp, could slow or even reverse Parkinson's symptoms, new research suggests, offering hope for new therapies. The study found that faulty cellular processes in the brain cause oxygen molecules to build up, damaging neurons and triggering symptoms. Restricting oxygen intake appeared to slow or even [...]

  • Flatworms can replace rats for breakthrough brain studies, researchers say

    Tiny pond worms could help find new ways to treat schizophrenia, develop understanding around drug addiction and test new medicines for mental illnesses – all while reducing the number of mice and rats used in early medical research. Scientists from the University of Reading say that planaria - harmless flatworms found in ponds and rivers [...]

  • Cure Parkinson’s announces £2m funding call for combination therapies

    In June, Cure Parkinson’s convened a workshop of researchers, organisations and individuals in the Parkinson’s community to focus on developing combination therapies. This informed the £2m funding call that the charity is announcing today that will open in October 2025. Currently, clinical trials for Parkinson’s have largely focussed on testing single drugs, or monotherapies, for [...]